Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-02-01 Sale |
2024-02-02 5:03 pm |
Centessa Pharmaceuticals plc | CNTA | Rotman Harris SVP Regulatory Affairs |
4,267 | $8.1027 | $34,574 | 137,625 (Direct) |
View |
| 2023-09-20 Sale |
2023-09-22 4:47 pm |
Centessa Pharmaceuticals plc | CNTA | Rotman Harris SVP Regulatory Affairs |
37,484 | $6.2877 | $235,688 | 170,916 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-02-01 Tax Withholding |
2024-02-02 5:03 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | Rotman Harris SVP Regulatory Affairs |
4,108 | $8.19 | 137,625 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-02 5:03 pm |
N/A 2034-02-01 |
Centessa Pharmaceuticals plc | CNTA | Rotman Harris SVP Regulatory Affairs |
112,500 | $0 | 137,625 (Direct) |
View |
| 2023-09-20 Exercise |
2023-09-22 4:47 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | Rotman Harris SVP Regulatory Affairs |
6,234 | $3.85 | 170,916 (Direct) |
View |
| 2023-09-20 Exercise |
2023-09-22 4:47 pm |
N/A 2032-08-01 |
Centessa Pharmaceuticals plc | CNTA | Rotman Harris SVP Regulatory Affairs |
37,484 | $0 | 170,916 (Direct) |
View |
| 2023-09-20 Exercise |
2023-09-22 4:47 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | Rotman Harris SVP Regulatory Affairs |
31,250 | $4.47 | 170,916 (Direct) |
View |
Ownership |
2023-06-23 5:01 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | Rotman Harris SVP Regulatory Affairs |
0 | $0 | 208,400 (Direct) |
View |